Illumina Stock Analysis


USD 205.62  4.80  2.28%   

The latest indifference towards the small price fluctuations of Illumina may raise some interest from institutional investors. The stock closed today at a share price of 205.62 on 836,980 in trading volume. The company management teams did not add any value to Illumina investors in November. However, most investors can still diversify their portfolios with Illumina to hedge their inherited risk against high-volatility market scenarios. The stock standard deviation of daily returns for 90 days investing horizon is currently 3.37. The above-average risk is mostly attributed to market volatility and speculations regarding some of the upcoming earning calls from Illumina partners.
Please see Risk vs Return Analysis.
The Illumina stock analysis report makes it easy to digest most publicly released information about Illumina and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. Illumina Stock analysis module also helps to analyze the Illumina price relationship with some important fundamental indicators such as market cap and management efficiency.

Illumina Stock Analysis Notes

About 91.0% of the company shares are owned by institutional investors. The company had not issued any dividends in recent years. Illumina had 2:1 split on the 23rd of September 2008. Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. The company was incorporated in 1998 and is based in San Diego, California. Illumina operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 9800 people. To learn more about Illumina call Jay Flatley at 858 202 4500 or check out

Illumina Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Illumina's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Illumina or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Illumina has very high historical volatility over the last 90 days
The company currently holds 1.7 B in liabilities with Debt to Equity (D/E) ratio of 0.38, which is about average as compared to similar companies. Illumina has a current ratio of 0.91, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Illumina until it has trouble settling it off, either with new capital or with free cash flow. So, Illumina's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Illumina sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Illumina to invest in growth at high rates of return. When we think about Illumina's use of debt, we should always consider it together with cash and equity.
Illumina has a strong financial position based on the latest SEC filings
Over 91.0% of Illumina shares are owned by institutional investors
Latest headline from Illumina gets EU antitrust charge sheet to unwind Grail acquisition swiftly - Yahoo Finance

Illumina Upcoming and Recent Events

Earnings reports are used by Illumina to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Illumina previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
Upcoming Quarterly Report10th of February 2022
Next Financial Report26th of April 2022
Next Fiscal Quarter End31st of December 2021
Next Fiscal Year End10th of February 2022
Last Quarter Report30th of September 2021
Last Financial Announcement31st of December 2020

Illumina SEC Filings

SEC filings are important regulatory documents required of all public companies to provide to potential investors. Illumina prospectus issued under the guidelines of SEC is a legal declaration of facts and statements to ensure that Illumina investors are not misled. SEC filings are required by law to meet strict transparency standards and other important legal constraints. Although many companies may choose careful wording to disguise some material information, SEC filings make crucial Illumina specific information freely available to individual and institutional investors to make a timely investment decision.
16th of September 2022
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
6th of September 2022
Financial Statements and Exhibits. Other Events
11th of August 2022
Financial Statements and Exhibits. Results of Operations and Financial Condition
14th of July 2022
Financial Statements and Exhibits. Other Events
9th of June 2022
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
27th of May 2022
Submission of Matters to a Vote of Security Holders
6th of May 2022
Financial Statements and Exhibits. Other Events
5th of May 2022
Financial Statements and Exhibits. Results of Operations and Financial Condition

Illumina Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Illumina is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Illumina backward and forwards among themselves. Illumina's institutional investor refers to the entity that pools money to purchase Illumina's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Security TypeSharesValue
Zweigdimenna Associates LlcCommon Shares7.9 K2.8 M
Zurich Insurance Group LtdCommon Shares26 K7.9 M
Zurich Insurance Group LtdCommon Shares25.1 K9.3 M
Zurich Insurance Group LtdCommon Shares24.1 K7.5 M
Zurich Insurance Group LtdCommon Shares24 K7.2 M
Zurich Insurance Group LtdCommon Shares23.5 K8.6 M
Zurich Insurance Group LtdCommon Shares43.5 K12.1 M
Zurcher Kantonalbank Zurich CantonalbankDebt585 K562 K
Note, although Illumina's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Illumina Market Capitalization

The company currently falls under 'Large-Cap' category with a current market capitalization of 33.1 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Illumina's market, we take the total number of its shares issued and multiply it by Illumina's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Illumina Profitablity

Illumina's profitability indicators refer to fundamental financial ratios that showcase Illumina's ability to generate income relative to its revenue or operating costs. If, let's say, Illumina is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Illumina's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Illumina's profitability requires more research than a typical breakdown of Illumina's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of (0.88) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of 0.04 %, which suggests for every 100 dollars of sales, it generated a net operating income of 0.0.
Last ReportedProjected for 2022
Return on Investment(1.34)  8.17 
Return on Average Assets 6.68  11.53 
Return on Average Equity 9.87  20.65 
Return on Invested Capital 0.19  0.28 
Return on Sales 0.21  0.33 

Management Efficiency

Return on Investment is expected to rise to 8.17 this year. Return on Average Assets is expected to rise to 11.53 this year. Illumina Return on Average Assets are quite stable at the moment as compared to the past year. The company's current value of Return on Average Assets is estimated at 11.53. Tangible Assets Book Value per Share is expected to rise to 32.57 this year, although the value of Total Assets will most likely fall to about 10.8 B. Illumina management efficiency ratios could be used to measure how well illumina manages its routine affairs as well as how well it operates its assets and liabilities.
Last ReportedProjected for 2022
Book Value per Share 71.60  47.59 
Enterprise Value over EBIT 64.00  48.42 
Enterprise Value over EBITDA 50.88  39.78 
Price to Book Value 5.54  9.02 
Tangible Assets Book Value per Share 32.36  32.57 
Enterprise Value60.9 B48.7 B
Tangible Asset Value4.9 B4.8 B
Long Term Debt Total
1.7 B
Non Current Liabilities Total
3.4 B
Short Long Term Debt Total
2.5 B
Interest Expense
61 M
Total Operating Expenses
3.3 B

Technical Drivers

As of the 9th of December, Illumina retains the Downside Deviation of 2.55, risk adjusted performance of 0.0445, and Market Risk Adjusted Performance of 0.0603. Illumina technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Simply put, you can use this information to find out if the firm will indeed mirror its model of historical price patterns, or the prices will eventually revert. We have collected data for nineteen technical drivers for Illumina, which can be compared to its competitors. Please check out Illumina coefficient of variation, treynor ratio, as well as the relationship between the Treynor Ratio and semi variance to decide if Illumina is priced fairly, providing market reflects its last-minute price of 205.62 per share. Given that Illumina has jensen alpha of (0.009587), we strongly advise you to confirm Illumina's regular market performance to make sure the company can sustain itself at a future point.

Illumina Price Movement Analysis

The minimum time period for execution of this function requires larger time horizon. Please increase the time horizon for this function. The output start index for this execution was zero with a total number of output elements of zero. The Instantaneous Trendline is a moving-average-like indicator which is formed by removing the Dominant Cycle from Illumina price series.

Illumina Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Illumina insiders, such as employees or executives, is commonly permitted as long as it does not rely on Illumina's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Illumina insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Illumina Predictive Daily Indicators

Illumina intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Illumina stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Illumina Forecast Models

Illumina time-series forecasting models is one of many Illumina's stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Illumina's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Illumina Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Illumina prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Illumina shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual Stock such as Illumina. By using and applying Illumina Stock analysis, traders can create a robust methodology for identifying Illumina entry and exit points for their positions.
Last ReportedProjected for 2022
Operating Margin(2.72)  10.16 
EBITDA Margin 26.43  37.18 
Gross Margin 69.69  71.60 
Profit Margin 16.84  22.75 

Current Illumina Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Illumina analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Illumina analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
Illumina current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Illumina analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Illumina stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Illumina, talking to its executives and customers, or listening to Illumina conference calls.
Illumina Analyst Advice Details

Illumina Stock Analysis Indicators

Illumina stock analysis indicators help investors evaluate how Illumina stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Illumina shares will generate the highest return on investment. By understating and applying Illumina stock analysis, traders can identify Illumina position entry and exit signals to maximize returns.
Begin Period Cash Flow1810000000.00
Logo U R LimglogosUSILMN.png
Common Stock Shares Outstanding151000000.00
Total Stockholder Equity10740000000.00
DescriptionIllumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the
Total Cashflows From Investing Activities-1069000000.00
Tax Provision122000000.00
Quarterly Earnings Growth Y O Y-0.452
Property Plant And Equipment Net1696000000.00
Retained Earnings5485000000.00
Cash And Short Term Investments1339000000.00
Retained Earnings Total Equity5485000000.00
Accounts Payable332000000.00
Net Debt1308000000.00
50 Day M A216.263
Total Current Liabilities1093000000.00
Currency CodeUSD
Other Operating Expenses4649000000.00
Non Current Assets Total12504000000.00
Forward Price Earnings76.9231
Common Stock Total Equity2000000.00
Non Currrent Assets Other445000000.00
Please see Risk vs Return Analysis. You can also try Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.

Complementary Tools for analysis

When running Illumina price analysis, check to measure Illumina's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Illumina is operating at the current time. Most of Illumina's value examination focuses on studying past and present price action to predict the probability of Illumina's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Illumina's price. Additionally, you may evaluate how the addition of Illumina to your portfolios can decrease your overall portfolio volatility.
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
CEO Directory
Screen CEOs from public companies around the world
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Is Illumina's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Illumina. If investors know Illumina will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Illumina listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
Market Capitalization
33.1 B
Quarterly Revenue Growth YOY
Return On Assets
Return On Equity
The market value of Illumina is measured differently than its book value, which is the value of Illumina that is recorded on the company's balance sheet. Investors also form their own opinion of Illumina's value that differs from its market value or its book value, called intrinsic value, which is Illumina's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Illumina's market value can be influenced by many factors that don't directly affect Illumina's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Illumina's value and its price as these two are different measures arrived at by different means. Investors typically determine Illumina value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Illumina's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.